Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
See Grinberg and Heinsen (doi:10.1093/brain/awx261) for a scientific commentary on this article. Clinical evidence suggests that aberrant tau accumulation in the locus coeruleus and noradrenergic dysfunction may be a critical early step in Alzheimer’s disease progression. Yet, an accurate preclinical model of these phenotypes that includes early pretangle tau accrual in the locus coeruleus, loss of locus coeruleus innervation and deficits locus coeruleus/norepinephrine modulated behaviours, does not exist, hampering the identification of underlying mechanisms and the development of locus coeruleus-based therapies. Here, a transgenic rat (TgF344-AD) expressing disease-causing mutant amyloid precursor protein (APPsw) and presenilin-1 (PS1ΔE9) was characterized for histological and behavioural signs of locus coeruleus dysfunction reminiscent of mild cognitive impairment/early Alzheimer’s disease. In TgF344-AD rats, hyperphosphorylated tau was detected in the locus coeruleus prior to accrual in the medial entorhinal cortex or hippocampus, and tau pathology in the locus coeruleus was negatively correlated with noradrenergic innervation in the medial entorhinal cortex. Likewise, TgF344-AD rats displayed progressive loss of hippocampal norepinephrine levels and locus coeruleus fibres in the medial entorhinal cortex and dentate gyrus, with no frank noradrenergic cell body loss. Cultured mouse locus coeruleus neurons expressing hyperphosphorylation-prone mutant human tau had shorter neurites than control neurons, but similar cell viability, suggesting a causal link between pretangle tau accrual and altered locus coeruleus fibre morphology. TgF344-AD rats had impaired reversal learning in the Morris water maze compared to their wild-type littermates, which was rescued by chemogenetic locus coeruleus activation via designer receptors exclusively activated by designer drugs (DREADDs). Our results indicate that TgF344-AD rats uniquely meet several key criteria for a suitable model of locus coeruleus pathology and dysfunction early in Alzheimer’s disease progression, and suggest that a substantial window of opportunity for locus coeruleus/ norepinephrine-based therapeutics exists.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The brain noradrenergic system is also critical for cognition and noradrengergic dysfunction is a critical early step in AD progression 249.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [249]
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
The efficiency of systematic sampling in stereology—reconsidered
GUNDERSEN, H. J. G., JENSEN, E. B. V., KIÊU, K., & NIELSEN, J. (1999) · Journal of Microscopy · doi:10.1046/j.1365-2818.1999.00457.x · Cited by 1,317
Augustinack, J. C., Schneider, A., Mandelkow, E.-M., & Hyman, B. T. (2002) · Acta Neuropathologica · doi:10.1007/s004010100423 · Cited by 998
The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies)
Amaral, D. G., Scharfman, H. E., & Lavenex, P. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63001-5 · Cited by 888
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Cited by
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365
“In animal models, lesions of the LC have been shown to exacerbate tau and amyloid-b plaque deposition, leading to depletion of noradrenaline in LC target regions and impaired cognitive function (Heneka, 2006; Kalinin et al., 2006, 2012; Jardanhazi-Kurutz et al., 2010; Chalermpalanupap et al., 2017; Rorabaugh et al., 2…”
BackgroundLong Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
Weinshenker, D. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.01.010 · Cited by 323
“, chemogenetic/optogenetic facilitation, NE prodrugs/agonists/reuptake inhibitors, aerobic exercise, environmental enrichment) could be of benefit, as already shown for animal models and in some human studies [16,17,21,30,42,130,131].”
InfluentialSelf-citationYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“The brain noradrenergic system is also critical for cognition and noradrenergic dysfunction is a critical early step in AD progression [249].”
BackgroundXiao, W., Su, J., Gao, X., Yang, H., Weng, R., Ni, W., & Gu, Y. (2022) · Microbiome · doi:10.1186/s40168-022-01255-6 · Cited by 252
“Hippocampal changes underlie the cognitive decline in chronological aging and CNS diseases like AD [54, 55].”
BackgroundJacobs, H. I. L., Becker, J. A., Kwong, K., Engels-Domínguez, N., Prokopiou, P. C., Papp, K. V., Properzi, M., Hampton, O. L., d’Oleire Uquillas, F., Sanchez, J. S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2511 · Cited by 228
Rostral locus coeruleus integrity is associated with better memory performance in older adults
Dahl, M. J., Mather, M., Düzel, S., Bodammer, N. C., Lindenberger, U., Kühn, S., & Werkle-Bergner, M. (2019) · Nature Human Behaviour · doi:10.1038/s41562-019-0715-2 · Cited by 223
Ross, J. A., & Van Bockstaele, E. J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.601519 · Cited by 207
“A Theory of Stress-Induced LC-NE Mediated Network Desynchronization Compelling pre-clinical (224, 225) and clinical evidence (226, 227) supports the involvement of the LC-NE system in Alzheimer’s Disease (AD) via the influence of Ars (Figure 5) on the processing of amyloid precursor protein (APP) (228–230), dysregulat…”
BackgroundVercruysse, P., Vieau, D., Blum, D., Petersén, Å., & Dupuis, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00002 · Cited by 172
“Indirect impact from early locus coeruleus impairments could also contribute to this phenomenon (Rorabaugh et al., 2017 and references herein; Guimarães et al., 2012 for review).”
BackgroundPentkowski, N. S., Rogge-Obando, K. K., Donaldson, T. N., Bouquin, S. J., & Clark, B. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.005 · Cited by 174
Matchett, B. J., Grinberg, L. T., Theofilas, P., & Murray, M. E. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02248-1 · Cited by 159
Dahl, M. J., Mather, M., Werkle‐Bergner, M., Kennedy, B. L., Guzman, S. J., Hurth, K. M., Miller, C. A., Qiao, Y., Shi, Y., Chui, H. C., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.11.006 · Cited by 152
Sales, A. C., Friston, K. J., Jones, M. W., Pickering, A. E., & Moran, R. J. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006267 · Cited by 145
Chalermpalanupap, T., Schroeder, J. P., Rorabaugh, J. M., Liles, L. C., Lah, J. J., Levey, A. I., & Weinshenker, D. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1483-17.2017 · Cited by 136
“Chemogenetic activation of the LC rescues hippocampal-dependent learning and memory in a rat model of AD with both tau and -amyloid pathology, suggesting that the acute neuromodulatory effects of NE may be more important than a chronic, neurotrophic influence on pathology (Rorabaugh et al., 2017).”
BackgroundSelf-citationα1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition
Perez, D. M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.581098 · Cited by 130
The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
Beardmore, R., Hou, R. H., Darekar, A., Holmes, C., & Boche, D. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210191 · Cited by 135
Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus
Kang, S. S., Liu, X., Ahn, E. H., Xiang, J., Manfredsson, F. P., Yang, X., Luo, H. R., Liles, L. C., Weinshenker, D., & Ye, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130513 · Cited by 123
“The Braak and Grinberg groups reported that hyperphosphorylated Tau emerges first in LC (Braak stage 0), but frank degeneration of LC neurons is not evident until Braak stage 3 to 4 (3, 6), although we have shown that pathogenic Tau induces LC fibers/terminals/NE loss before cell body death in animal models (11, 14).”
BackgroundSelf-citationWhen the Locus Coeruleus Speaks Up in Sleep: Recent Insights, Emerging Perspectives
Osorio-Forero, A., Cherrad, N., Banterle, L., Fernandez, L. M. J., & Lüthi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095028 · Cited by 116
A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
Levey, A. I., Qiu, D., Zhao, L., Hu, W. T., Duong, D. M., Higginbotham, L. A., Dammer, E. B., Seyfried, N. T., Wingo, T. S., Hales, C. M., et al. (2021) · Brain · doi:10.1093/brain/awab452 · Cited by 110
Self-citationBetts, M. J., Cárdenas‐Blanco, A., Kanowski, M., Spottke, A. E., Teipel, S. J., Kilimann, I., Jessen, F., & Düzel, E. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.02.001 · Cited by 122
Koh, W., Park, M., Chun, Y. E., Lee, J., Shim, H. S., Park, M. G., Kim, S., Sa, M., Joo, J., Kang, H., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.10.012 · Cited by 95
“Chemogenetic activation of the locus coeruleus (LC) can restore cognitive flexibility in a model of early stages of AD (29), suggesting an important role of NE in cognitive flexibility.”
BackgroundAnxiety-like behavior as an early endophenotype in the TgF344-AD rat model of Alzheimer's disease
Pentkowski, N. S., Berkowitz, L. E., Thompson, S. M., Drake, E., Maestas-Olguin, C. R., & Clark, B. J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.024 · Cited by 94
Chaney, A. M., Lopez‐Picon, F. R., Sérrière, S., Wang, R., Bochicchio, D., Webb, S. D., Vandesquille, M., Harte, M., Georgiadou, C., Lawrence, C. B., et al. (2021) · Theranostics · doi:10.7150/thno.56059 · Cited by 77
“Conversely, the levels of Tau deposition in this model have now been consistently reported by us and others [12, 19, 28], suggesting that this rat model reproduces this essential feature of AD.”
ResultInfluentialNoradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing
Orlando, I. F., Shine, J. M., Robbins, T. W., Rowe, J. B., & O’Callaghan, C. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105167 · Cited by 83
“in rodent models of Alzheimer’s disease (Omoluabi et al., 2021; Rorabaugh et al., 2017).”
Balu, D. T., Pantazopoulos, H., Huang, C. C., Muszynski, K., Harvey, T. L., Uno, Y., Rorabaugh, J. M., Galloway, C. R., Botz-Zapp, C. A., Berretta, S., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104511 · Cited by 80
Self-citationImpairments of attention in Alzheimer’s disease
Malhotra, P. (2018) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.11.002 · Cited by 89
Poon, C. H., Wang, Y., Fung, M., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1026 · Cited by 85
“The TgF344-AD rat exhibited reversal learning declines in the MWM at 6 months [110] and learning deficits in the Barnes maze at 15 months [109].”
BackgroundDahl, M., Bachman, S., Dutt, S., Düzel, S., Bodammer, N., Lindenberger, U., Kühn, S., Werkle‐Bergner, M., & Mather, M. (2023) · Nature Aging · doi:10.1016/j.clinph.2023.02.013 · Cited by 87
Unraveling the contributions to the neuromelanin-MRI contrast
Priovoulos, N., van Boxel, S. C. J., Jacobs, H. I. L., Poser, B. A., Uludaǧ, K., Verhey, F. R. J., & Ivanov, D. (2020) · Brain Structure and Function · doi:10.1007/s00429-020-02153-z · Cited by 80
“, due to the reduced density of the long projections of the LC (Keuken et al. 2017; Okubo et al. 2017; Rorabaugh et al. 2017; Steen et al. 1995).”
BackgroundEhrenberg, A. J., Kelberman, M. A., Liu, K. Y., Dahl, M. J., Weinshenker, D., Falgàs, N., Dutt, S., Mather, M., Ludwig, M., Betts, M. J., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12937 · Cited by 74
Self-citationBerkowitz, L. E., Harvey, R. E., Drake, E., Thompson, S. M., & Clark, B. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34368-w · Cited by 72
Xia, S.-H., Hu, S.-W., Ge, D.-G., Liu, D., Wang, D., Zhang, S., Zhang, Q., Yuan, L., Li, Y., Yang, J., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.013 · Cited by 74
Siddik, M. A. B., Mullins, C. A., Kramer, A., Shah, H., Gannaban, R. B., Zabet-Moghaddam, M., Huebinger, R. M., Hegde, V. K., MohanKumar, S. M. J., MohanKumar, P. S., et al. (2022) · Cells · doi:10.3390/cells11213523 · Cited by 68
Ghosh, A., Torraville, S. E., Mukherjee, B., Walling, S. G., Martin, G. M., Harley, C. W., & Yuan, Q. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0511-2 · Cited by 75
Hippocampal Deficits in Amyloid-β-Related Rodent Models of Alzheimer’s Disease
Vyas, Y., Montgomery, J. M., & Cheyne, J. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00266 · Cited by 66
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 73
“Furthermore, the learning impairment observed in these rats was reversed by LC chemogenetic activation (Rorabaugh et al., 2017).”
BackgroundMethodGoodman, A. M., Langner, B. M., Jackson, N. L., Alex, C., & McMahon, L. L. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0119-21.2021 · Cited by 67
Butkovich, L. M., Houser, M. C., Chalermpalanupap, T., Porter‐Stransky, K. A., Iannitelli, A. F., Boles, J. S., Lloyd, G. M., Coomes, A. S., Eidson, L. N., Rodrigues, M. E. D. S., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1468-19.2020 · Cited by 69
Self-citationAnckaerts, C., Blockx, I., Summer, P., Michael, J., Hamaide, J., Kreutzer, C., Boutin, H., Couillard‐Després, S., Verhoye, M., & der Linden, A. V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.010 · Cited by 66
Morrone, C. D., Bazzigaluppi, P., Beckett, T. L., Hill, M. E., Koletar, M. M., Stefanovic, B., & McLaurin, J. (2019) · Brain · doi:10.1093/brain/awz371 · Cited by 68
Locus coeruleus in memory formation and Alzheimer's disease
James, T., Kula, B., Choi, S., Khan, S. S., Bekar, L. K., & Smith, N. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15045 · Cited by 66
“Interestingly, concomitant alterations in GFAP + and Iba1 + glial cells were observed in the LC of 16-month-old TgF344 AD model rats, and infusion of human pseudo-phospho-tau into the LC resulted in the accumulation of human tau into cortical neurons and microglia (Ghosh et al., 2019; Rorabaugh et al., 2017).”
BackgroundLocus coeruleus in the pathogenesis of Alzheimer's disease: A systematic review
Chen, Y., Chen, T., & Hou, R. H. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12257 · Cited by 82
Liu, W., Li, J., Yang, M., Ke, X., Dai, Y., Lin, H., Wang, S., Chen, L., & Tao, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-00994-w · Cited by 66
“Chemical genetic technology has been successfully applied in 5XFAD mice to reduce the deposition of Aβ plaque [56] and has been applied to improve cognitive function in AD rat models by stimulating noradrenergic neurons in the locus coeruleus [57].”
MethodSpatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition
Bueichekú, E., Diez, I. P., Kim, C. M., Becker, J. A., Koops, E. A., Kwong, K. K., Papp, K. V., Salat, D. H., Bennett, D. A., Rentz, D. M., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00626-y · Cited by 72
“Animal studies demonstrated that accumulation of hyperphosphorylated tau in the LC was associated with impaired hippocampal-mediated memory, reduced hippocampal NE levels and decreased LC fiber density in the MTL 20,21,32 .”
Dammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Gerasimov, E. S., Ravindran, S. P., Gudmundsdottir, V., Frick, E. A., Gomez, G. T., Walker, K. A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adn3504 · Cited by 54
“Increasing brain norepinephrine has positive effects in preclinical AD models ( 33 ) and had a beneficial effect on CSF tTau and pTau181 and brain metabolic function as assessed by [ 18 F]fluorodeoxyglucose positron emission tomography (PET) after 6 months of ATX treatment in the phase 2 clinical…”
MethodTau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation
Kang, S. S., Meng, L., Zhang, X., Wu, Z., Mancieri, A., Xie, B., Liu, X., Weinshenker, D., Peng, J., Zhang, Z., et al. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00745-3 · Cited by 58
“Research in animal models has shown that LC dysfunction and degeneration contribute to the progression of forebrain pathology and cognitive impairment 12,48–50 , whereas restoration of noradrenergic signaling can ameliorate AD-like symptoms 7,51 .”
BackgroundSelf-citationWang, J., Yang, C., Wang, H., Li, D., Li, T., Sun, Y., Zhao, M., Ma, J., Hua, W., & Yang, Z. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00086 · Cited by 50
Kelberman, M. A., Rorabaugh, J. M., Anderson, C. R., Marriott, A., DePuy, S. D., Rasmussen, K., McCann, K. E., Weiss, J. M., & Weinshenker, D. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.01.016 · Cited by 53
Self-citationCeyzériat, K., Gloria, Y., Tsartsalis, S., Fossey, C., Cailly, T., Fabis, F., Millet, P., & Tournier, B. B. (2021) · Brain Communications · doi:10.1093/braincomms/fcab029 · Cited by 44
ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease
Kang, S. S., Ahn, E. H., Liu, X., Bryson, M., Miller, G. W., Weinshenker, D., & Ye, K. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02315-1 · Cited by 54
Self-citationSaggu, S., Bai, A., Aida, M., Rehman, H., Pless, A., Ware, D., Deák, F., Jiao, K., & Wang, Q. (2024) · GeroScience · doi:10.1007/s11357-024-01359-x · Cited by 54
“Chemogenetic activation of the locus coeruleus in transgenic rats also alleviated learning impairments [210].”
Slater, C. L., & Wang, Q. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.397 · Cited by 50
Morrone, C. D., Lai, A. Y., Bishay, J., Hill, M. E., & McLaurin, J. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00300-6 · Cited by 43
“TgF344-AD rats exhibit hyperphosphorylated tau inclusions consisting of endogenous rat tau [20, 21, 24].”
BackgroundResultInfluentialNoradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
Gutiérrez, I. L., Russo, C. D., Novellino, F., Caso, J. R., García‐Bueno, B., Leza, J. C., & Madrigal, J. L. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116143 · Cited by 55
“Thus, learning impairments observed in transgenic rats were reduced when the LC was stimulated through DREADDs [160].”
BackgroundKelberman, M. A., Keilholz, S. D., & Weinshenker, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.583421 · Cited by 48
Self-citationIannitelli, A. F., Kelberman, M. A., Lustberg, D. J., Korukonda, A., McCann, K. E., Mulvey, B., Segal, A., Liles, L. C., Sloan, S. A., Dougherty, J. D., et al. (2022) · eNeuro · doi:10.1523/eneuro.0483-22.2022 · Cited by 50
“Furthermore, GFAP1, IBA11, and S100B 1 cells were quantified based on size and shape for glia (50– 1000 mm2, circularity 0.15–1.0; Rorabaugh et al., 2017).”
MethodInfluentialSelf-citationvan den Berg, M., Toen, D. V., Verhoye, M., & Keliris, G. A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1081058 · Cited by 43
“In addition, TgF344-AD rats display p-tau accumulation in the locus coeruleus from 6 months onwards (Rorabaugh et al., 2017).”
BackgroundKelly, S. C., McKay, E. C., Beck, J. S., Collier, T. J., Dorrance, A. M., & Counts, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190090 · Cited by 46
“Thismaybeduetomethodologicaldiffer-ences (e.g., free-floating versus paraffin-embedded tissue [38]) or even age-related phenotypic differences between our colony and others.”
InfluentialKelberman, M. A., Anderson, C. R., Chlan, E., Rorabaugh, J. M., McCann, K. E., & Weinshenker, D. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215546 · Cited by 43
“In this study, we expanded on our previous work demonstrating that TgF344-AD rats have progressive noradrenergic fiber loss [63] by also showing lower NET+ fiber density in TgF344-AD rats, specifically in the DG.”
InfluentialSelf-citationThe ‘a, b, c’s of pretangle tau and their relation to aging and the risk of Alzheimer’s Disease
Harley, C. W., Walling, S. G., Yuan, Q., & Martin, G. M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.12.010 · Cited by 43
Evans, A. K., Defensor, E. B., & Shamloo, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1030609 · Cited by 41
“hyperphosphorylation of tau in the LC, loss of hippocampal and cortical NE fibers, impaired reversal learning in the Morris Water Maze, and behavioral deficits were reversed with chemogenetic activation of the LC (Rorabaugh et al., 2017).”
BackgroundNeurochemical and cognitive changes precede structural abnormalities in the TgF344-AD rat model
Fowler, C., Goerzen, D., Devenyi, G. A., Madularu, D., Chakravarty, M. M., & Near, J. (2022) · Brain Communications · doi:10.1093/braincomms/fcac072 · Cited by 37
Pillet, L., Taccola, C., Cotoni, J., Thiriez, H., André, K., & Verpillot, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0841-7 · Cited by 41
Bernaud, V. E., Bulen, H. L., Peña, V., Koebele, S. V., Northup-Smith, S. N., Manzo, A. A., Sanchez, M. V., Opachich, Z., Ruhland, A., & Bimonte‐Nelson, H. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-18415-1 · Cited by 31
“There was a main effect of Delay for WMC errors for the 12-month WT group [F(1,9) = 15.”
BackgroundBac, B., Hicheri, C., Weiss, C., Buell, A., Vilcek, N., Späni, C. B., Geula, C., Savas, J. N., & Disterhoft, J. F. (2022) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2022.12.015 · Cited by 31
A new perspective on Alzheimer’s disease: m6A modification
Xia, L., Zhang, F., Li, Y., Mo, Y., Zhang, L., Li, Q., Luo, M., Hou, X., Du, Z., Deng, J., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1166831 · Cited by 34
Level of hM4D(Gi) DREADD Expression Determines Inhibitory and Neurotoxic Effects in the Hippocampus
Goossens, M., Larsen, L. E., Vergaelen, M., Wadman, W. J., den Haute, C. V., Brackx, W., Proesmans, S., Desloovere, J., Christiaen, E., Craey, E., et al. (2021) · eNeuro · doi:10.1523/eneuro.0105-21.2021 · Cited by 37
“…AAV serotypes but similar viral titers and injected volumes, DREADDs were expressed in the hippocampus (PanozBrown et al., 2018) or in a different brain region such as the retrosplenial cortex (Robinson et al., 2014), locus coeruleus (Rorabaugh et al., 2017), or striatum (Aldrin-Kirk et al., 2016).”
BackgroundMethodInfluentialA case-control study of the locus coeruleus degeneration in Alzheimer's disease
Hou, R. H., Beardmore, R., Holmes, C., Osmond, C., & Darekar, A. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.12.013 · Cited by 29
Xiao, W., Yang, Y., Bai, L., Yang, P., Li, R., Yang, D., Li, F., Quan, L., Liang, Q., Yan, Y., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03493-5 · Cited by 36
Chaudry, O., Ndukwe, K., Xie, L., Figueiredo-Pereira, M., Serrano, P., & Rockwell, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23801-w · Cited by 28
Fang, X., Border, J. J., Rivers, P. L., Zhang, H., Williams, J. M., Fan, F., & Roman, R. J. (2023) · GeroScience · doi:10.1007/s11357-023-00841-2 · Cited by 26
Tournier, B. B., Barca, C., Fall, A. B., Gloria, Y., Meyer, L., Ceyzériat, K., & Millet, P. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12712 · Cited by 31
“However, another study showed an impaired reversal learning in the Morris water maze in TgF344-AD rats at 6 months of age.(24) Hippocampus-dependent working memory disorders have also been described at 12 and 24 months of age using the novel object recognition test.”
BackgroundMethodSrivastava, H. K., Lasher, A. T., Nagarajan, A., & Sun, L. Y. (2023) · Aging Cell · doi:10.1111/acel.13854 · Cited by 28
“When Morris water maze testing, another assessment of learning and memory, is employed impaired cognition has been reported in Tg rats aged from 6 to 24 months old (Rorabaugh et al., 2017; Voorhees et al., 2018).”
MethodObesity during preclinical Alzheimer's disease development exacerbates brain metabolic decline
Anderson, T., Sharma, S. K., Kelberman, M. A., Ware, C. B., Guo, N., Qin, Z. S., Weinshenker, D., & Parent, M. B. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15900 · Cited by 26
“As we have previously reported, AD rats at a later stage have lower hippocampal NE levels than WT rats (Goodman et al., 2021; Kelberman et al., 2022 ; Rorabaugh et al., 2017).”
BackgroundInfluentialSelf-citationAlteration of Neural Pathways and Its Implications in Alzheimer’s Disease
Kim, S., Nam, Y., Kim, H. S., Jung, H., Jeon, S. G., Hong, S. B., & Moon, M. (2022) · Biomedicines · doi:10.3390/biomedicines10040845 · Cited by 36
Zong, B., Yu, F., Zhang, X., Zhao, W., Sun, P., Li, S., & Li, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.869507 · Cited by 39
van den Berg, M., Adhikari, M. H., Verschuuren, M., Pintelon, I., Vasilkovska, T., Audekerke, J. V., Missault, S., Heymans, L., Ponsaerts, P., Vos, W. H. D., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01089-2 · Cited by 29
“A previous study has observed pTau accumulation in the locus coeruleus observed at 6 months of age in TgF344AD rats [37], similar to our observation in the current study.”
MethodResultVentral Tegmental Area in Prodromal Alzheimer’s Disease: Bridging the Gap between Mice and Humans
D’Amelio, M., Serra, L., & Bozzali, M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180094 · Cited by 28
“This lastpointiscrucialasLCwidelyprojectstobrain areasimportantforlearningandmemory,andisone oftheearliestbrainregionsaffected[12,13].”
Gallo, A., Pillet, L., & Verpillot, R. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111452 · Cited by 28
Qin, T., Prins, S., Groeneveld, G. J., van Westen, G. J. P., de Vries, H. E., Wong, Y. C., Bischoff, L. J. M., & de Lange, E. C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093158 · Cited by 27
Tudela, R., Muñoz‐Moreno, E., Sala‐Llonch, R., López-Gil, X., & Sòria, G. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00213 · Cited by 24
Lanni, I., Chiacchierini, G., Papagno, C., Santangelo, V., & Campolongo, P. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105831 · Cited by 23
“Rorabaugh and colleagues conducted a study on the effect of che-mogenetic techniques on the activation of LC neurons induced by hM3Dq DREADDs (Rorabaugh et al., 2017).”
BackgroundInfluentialAcute vagus nerve stimulation enhances reversal learning in rats
Altidor, L., Bruner, M. M., Deslauriers, J. F., Garman, T. S., Ramirez, S., Dirr, E. W., Olczak, K. P., Maurer, A. P., Lamb, D. G., Otto, K. J., et al. (2021) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2021.107498 · Cited by 21
Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease
Lopes, P. A., & Guil‐Guerrero, J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125541 · Cited by 26
Nguyen, P., & Gelinas, J. N. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1497630 · Cited by 25
“Animal models of AD often express impaired hippocampal LTP and defective hippocampus-dependent memory (for instance, Li et al., 2017; Liu et al., 2008), and some evidence suggests that noradrenergic supplementation can improve memory in such models (Rorabaugh et al., 2017).”
BackgroundAhnaou, A., & Drinkenburg, W. H. I. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.039 · Cited by 26
Giorgi, F. S., Martini, N., Lombardo, F. P., Galgani, A., Bastiani, L., Latta, D. D., Hlavata, H., Busceti, C. L., Biagioni, F., Puglisi‐Allegra, S., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02486-5 · Cited by 19
Hernandez, C. M., Jackson, N. L., Hernandez, A. R., & McMahon, L. L. (2022) · eNeuro · doi:10.1523/eneuro.0181-22.2022 · Cited by 25
de Leo, G., Gulino, R., Coradazzi, M., & Leanza, G. (2022) · Brain Communications · doi:10.1093/braincomms/fcac338 · Cited by 22
Prokopiou, P. C., Engels, N., Schultz, A. P., Sepulcre, J., Koops, E. A., Papp, K. V., Marshall, G. A., Normandin, M. D., Fakhri, G. E., Rentz, D. M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207646 · Cited by 24
“Furthermore, transgenic rats with LC tau pathology exhibited the loss of NE in medial temporal lobe regions that was associated with decrease in LC fiber density and impaired learning, which can be rescued by the chemogenetic activation of LC.10 Correspondingly, our fMRI-task involved detecting and processing novel in…”
BackgroundInfluentialPillet, L., Taccola, C., Cotoni, J., Thiriez, H., André, K., & Verpillot, R. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01102-y · Cited by 20
Wan, J., Gong, Y., Xu, Z., Dong, X., Wei, G., & Zhang, Q. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106541 · Cited by 20
Hassanein, L., Mulvey, B., Blankenship, H. E., Tish, M., Korukonda, A., Liles, L. C., Sharpe, A. L., Paré, J., Villalba, R. M., Chen, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.07.530845 · Cited by 20
Self-citationPentkowski, N. S., Bouquin, S. J., Maestas-Olguin, C. R., Villasenor, Z. M., & Clark, B. J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113661 · Cited by 18
Huang, H., Deng, X., Wang, Y., Shen, S., Wang, S., Hu, M., Liu, S., Su, X., Li, C., Li, T., et al. (2024) · Advanced Science · doi:10.1002/advs.202404096 · Cited by 18
Rasmussen, S. A., Daenzer, J. M. I., MacWilliams, J., Head, S. T., Williams, M. B., Geurts, A. M., Schroeder, J. P., Weinshenker, D., & Fridovich‐Keil, J. L. (2019) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12205 · Cited by 17
“To assess motor and cognitive functions of our GALTnull rats, we subjected adult males, all 4-5 months old, to both a rotarod activity(17) and a Morris water maze with hidden platform.(18) As reported for motor(19) and cognitive outcomes in patients,(16) we saw a range of performance TABLE 1 Leloir pathway enzyme acti…”
MethodSelf-citationGao, D., Wan, J., Zou, Y. F., Gong, Y., Dong, X., Xu, Z., Tang, J., Wei, G., & Zhang, Q. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01754g · Cited by 18
Delbono, O., Wang, Z., & Messi, M. L. (2022) · Acta Physiologica · doi:10.1111/apha.13887 · Cited by 21
Diverse ancestral brainstem noradrenergic neuron activity across species and biological factorsPreprint
Kelberman, M. A., Rodberg, E. M., Munn, B. R., Arabzadeh, E., Bair-Marshall, C. J., Berridge, C. W., Berrocoso, E., Breton‐Provencher, V., Chandler, D. J., Che, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.14.618224 · Cited by 25
“Moreover, age heavily impacts LC structure and function, such as preclinical studies that have reported LC cell body and axon loss over the course of aging ( 43-47 ).”
Self-citationUsing Inhibitory DREADDs to Silence LC Neurons in Monkeys
Pérez, P., Chavret-Reculon, E., Ravassard, P., & Bouret, S. (2022) · Brain Sciences · doi:10.3390/brainsci12020206 · Cited by 19
Downs, A. M., Catavero, C. M., Kasten, M. R., & McElligott, Z. A. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.08.008 · Cited by 19
Metadata
- Authors
- Rorabaugh, J. M., Chalermpalanupap, T., Botz-Zapp, C. A., Fu, V. M., Lembeck, N. A., Cohen, R. M., & Weinshenker, D.
- Affiliations
- Emory University (US)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-25
- Volume
- 140
- Issue
- 11
- Pages
- 3023-3038
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC5841201
- OpenAlex
- W2760256027
- Cited by
- 227
- References
- 72
- Citations by year
- 2026: 24 · 2025: 25 · 2024: 39 · 2023: 20 · 2022: 45 · 2021: 26 · 2020: 18 · 2019: 14 · 2018: 13 · 2017: 3
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Brain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG0476670, NS007480)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- locus coeruleus, Alzheimer's disease, reversal learning, tau hyperphosphorylation, noradrenergic dysfunction, norepinephrine, TgF344-AD rats, medial entorhinal cortex, DREADD, chemogenetic activation, mild cognitive impairment, preclinical models
- MeSH terms
- Alzheimer Disease, Animals, Cells, Cultured, Disease Models, Animal, Female, Locus Coeruleus, Male, Rats, Inbred F344, Reversal Learning, tau Proteins, Maze Learning, Rats, Rats, Transgenic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.